Zomedica to Present at H.C. Wainwright BioConnect 2022 Conference

Zomedica Corp. (NYSE American: ZOM) announced that CEO Larry Heaton will present a company overview at the virtual H.C.

Rhea-AI Summary

Zomedica Corp. (NYSE American: ZOM) announced that CEO Larry Heaton will present a company overview at the virtual H.C. Wainwright BioConnect 2022 Conference from January 10-13, 2022. The presentation will be available on-demand starting January 10 at 7:00 am ET for registered attendees and the public at this link, and on Zomedica's website thereafter. The company focuses on providing innovative diagnostic and therapeutic products for companion animals, aiming to enhance the productivity and revenue for veterinary practices.

Argus Session date unavailable

+3.04% session move Open Argus

Details

News Market Reaction – ZOM

The recorded move for ZOM in the trading session of this news was +3.04%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ANN ARBOR, MI / ACCESSWIRE / December 15, 2021 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced today that Larry Heaton, Chief Executive Officer, will present a company overview at the upcoming virtual H.C. Wainwright BioConnect 2022 Conference, scheduled for January 10-13, 2022.

The presentation will be available on-demand beginning January 10, at 7:00 am ET to registered conference attendees and the public at: https://journey.ct.events/view/67b1dab2-8dd0-4f50-8291-86cf6c38ed3b, and subsequently on the Zomedica website at: https://investors.zomedica.com/events-presentations.

About Zomedica

Based in Ann Arbor, Michigan, Zomedica (NYSE American:ZOM) is a veterinary health company offering diagnostic and therapeutic products for companion animals by focusing on the unmet needs of clinical veterinarians. Zomedica's product portfolio of innovative diagnostics and medical devices are designed to improve both patient and practice health. Zomedica's mission is to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. For more information, visit www.ZOMEDICA.com.

Follow Zomedica

• Email Alerts: http://investors.zomedica.com
• LinkedIn: https://www.linkedin.com/company/zomedica

Investor Relations Contacts

PCG Advisory Group
Kirin Smith, President
ksmith@pcgadvisory.com
+1.646.823.8656

SOURCE: Zomedica Corp.

View source version on accesswire.com:
https://www.accesswire.com/677803/Zomedica-to-Present-at-HC-Wainwright-BioConnect-2022-Conference

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Zomedica present at the H.C. Wainwright BioConnect 2022 Conference?

Zomedica will present at the H.C. Wainwright BioConnect 2022 Conference from January 10-13, 2022.

How can I watch Zomedica's presentation at the conference?

You can watch Zomedica's presentation on-demand starting January 10 at 7:00 am ET at this link: https://pr.report/KsflCopv.

What is Zomedica's focus in the veterinary health sector?

Zomedica focuses on offering innovative diagnostic and therapeutic products for companion animals, addressing unmet needs in clinical veterinary practices.

Where can I find more information about Zomedica?

More information about Zomedica can be found on their website at www.zomedica.com.

Who is presenting for Zomedica at the BioConnect 2022 Conference?

Larry Heaton, the CEO of Zomedica, will present at the H.C. Wainwright BioConnect 2022 Conference.